About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Drug News » FDA Advisory Committee Backs Pfizer’s Pneumonia Vaccine for Use in Adults

FDA Advisory Committee Backs Pfizer’s Pneumonia Vaccine for Use in Adults

by Kathy Jones on Nov 17 2011 8:38 PM

FDA Advisory Committee Backs Pfizer’s Pneumonia Vaccine for Use in Adults

Pfizer’s pneumonia vaccine for children, Prevnar 13, has been backed by an FDA advisory committee to be used in treating diseases caused by pneumococcus bacteria in adults.

The advisory committee voted 14-1 in favor of using the vaccine in adults and with FDA usually approving products backed by the committee, Prevnar is expected to be approved for treating pneumonia disease among adults.

Pneumonia - Causes, Symptoms, Diagnosis, Treatment, Prevention, Complications

Pneumonia - Causes, Symptoms, Diagnosis, Treatment, Prevention, Complications
Pneumonia is a lung infection that can be caused by a bacteria or a virus. It causes inflammation of the alveoli or the air sacs of the lungs.

The health regulator is said to be considering placing the vaccine on an accelerated approval process and will reach a decision soon on whether to approve the vaccine to be used in adults over 50 years of age.

The vaccine, which was approved in October 2010 for preventing diseases caused by S. pneumoniae serotypes in children, generated over $3.7 billion in sales worldwide and Pfizer revealed that it could generate an additional $1.5 billion annually if it is approved for adults.

Source-Medindia

Hib Vaccine - Types, Dosage Schedule, Contraindications and Side Effects

Hib Vaccine - Types, Dosage Schedule, Contraindications and Side Effects
The Hib vaccine protects children against infections like meningitis and pneumonia that are caused by the Haemophilus influenzae type b bacterium.

Respiratory Diseases - Diseases of the Human Respiratory System

Respiratory Diseases - Diseases of the Human Respiratory System
Respiratory diseases affect any part of the respiratory system. Some of the lung diseases like chronic obstructive pulmonary disease can lead to respiratory failure.

Recommended Readings

Hib Vaccine

The Hib vaccine protects children against infections like meningitis and pneumonia that are caused by the Haemophilus influenzae type b bacterium.

Cough Symptom Evaluation

Cough Symptom Evaluation

Cough is a symptom of a condition usually affecting the respiratory tract. It may be acute or chronic, wet or dry. The type of cough can help the physician diagnose the underlying condition.

Silicosis

Silicosis is a lung disease caused by inhalation of crystalline free silica dust. It is characterised by nodular pulmonary fibrosis.

Legionnaires’ disease

Legionnaires’ disease

Legionnaires’ disease is a severe form of pneumonia caused by a type of bacteria. The infection is likely to spread when people inhale tiny water droplets containing the bacteria.

RSV (Respiratory Syncytial Virus) in Children

RSV (Respiratory Syncytial Virus) in Children

Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections. RSV infection is usually mild and self-limiting but symptoms may be severe in young children, the elderly and those with a weak immunity.

Top 10 Vaccine Myths Debunked

Top 10 Vaccine Myths Debunked

Childhood vaccination has saved many lives, yet lots more has to be done to increase awareness and eliminate myths regarding vaccines.

Latest Drug News

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

The US FDA approves a immunotherapy drug, N-803, for BCG-unresponsive non-muscle invasive bladder cancer, suggested to be used in conjunction with BCG.

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.

Semaglutide: A Dominant Player for Patients With Heart Failure

Semaglutide: A Dominant Player for Patients With Heart Failure

Data provesSemaglutideefficacy in treatment of Type 2 diabetes, obesity, heart failure, and chronic kidney failure, it emerges as important therapy in metabolic syndrome.

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Generics are not widely used, despite cost advantage, due to a lack of information to patients and reluctance from physicians to prescribe generics - A Need to educate masses

Drug Resistant Melanoma Caused Due to Break in Genes!

Drug Resistant Melanoma Caused Due to Break in Genes!

Studies have led to discovery that drug-resistant melanomas are caused by breaks in the genes, thereby leading to emphasis on alternate targeted therapies to combat cancer.

Advertisement